메뉴 건너뛰기




Volumn 108, Issue 31, 2011, Pages 12943-12948

Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting

Author keywords

Biodiversity; Drug prolific species; Herb; Phylogenetic tree

Indexed keywords

ANTIINFECTIVE AGENT; NATURAL PRODUCT;

EID: 79961223344     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1107336108     Document Type: Article
Times cited : (228)

References (59)
  • 1
    • 34247109045 scopus 로고    scopus 로고
    • Natural products as sources of new drugs over the last 25 years
    • Newman DJ, Cragg GM (2007) Natural products as sources of new drugs over the last 25 years. J Nat Prod 70:461-477.
    • (2007) J Nat Prod , vol.70 , pp. 461-477
    • Newman, D.J.1    Cragg, G.M.2
  • 2
    • 44249098800 scopus 로고    scopus 로고
    • Natural products to drugs: Natural product-derived compounds in clinical trials
    • Butler MS (2008) Natural products to drugs: Natural product-derived compounds in clinical trials. Nat Prod Rep 25:475-516.
    • (2008) Nat Prod Rep , vol.25 , pp. 475-516
    • Butler, M.S.1
  • 3
    • 77649234756 scopus 로고    scopus 로고
    • How to improve R&D productivity: The pharmaceutical industry's grand challenge
    • Paul SM, et al. (2010) How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat Rev Drug Discov 9:203-214.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 203-214
    • Paul, S.M.1
  • 4
    • 67650436176 scopus 로고    scopus 로고
    • Drug discovery and natural products: End of an era or an endless frontier?
    • Li JW, Vederas JC (2009) Drug discovery and natural products: End of an era or an endless frontier? Science 325:161-165.
    • (2009) Science , vol.325 , pp. 161-165
    • Li, J.W.1    Vederas, J.C.2
  • 5
    • 77953018255 scopus 로고    scopus 로고
    • Global biodiversity: Indicators of recent declines
    • Butchart SH, et al. (2010) Global biodiversity: Indicators of recent declines. Science 328:1164-1168.
    • (2010) Science , vol.328 , pp. 1164-1168
    • Butchart, S.H.1
  • 6
    • 41549115075 scopus 로고    scopus 로고
    • Assessing drug-likeness - What are we missing?
    • Vistoli G, Pedretti A, Testa B (2008) Assessing drug-likeness - what are we missing? Drug Discov Today 13:285-294.
    • (2008) Drug Discov Today , vol.13 , pp. 285-294
    • Vistoli, G.1    Pedretti, A.2    Testa, B.3
  • 7
    • 0029894013 scopus 로고    scopus 로고
    • The properties of known drugs. 1. Molecular frameworks
    • Bemis GW, Murcko MA (1996) The properties of known drugs. 1. Molecular frameworks. J Med Chem 39:2887-2893.
    • (1996) J Med Chem , vol.39 , pp. 2887-2893
    • Bemis, G.W.1    Murcko, M.A.2
  • 8
    • 75749105013 scopus 로고    scopus 로고
    • Drug and drug candidate building block analysis
    • Wang J, Hou T (2010) Drug and drug candidate building block analysis. J Chem Inf Model 50:55-67.
    • (2010) J Chem Inf Model , vol.50 , pp. 55-67
    • Wang, J.1    Hou, T.2
  • 9
    • 36749018204 scopus 로고    scopus 로고
    • Privileged structures: A useful concept for the rational design of new lead drug candidates
    • Duarte CD, Barreiro EJ, Fraga CA (2007) Privileged structures: A useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem 7:1108-1119.
    • (2007) Mini Rev Med Chem , vol.7 , pp. 1108-1119
    • Duarte, C.D.1    Barreiro, E.J.2    Fraga, C.A.3
  • 10
    • 28444498830 scopus 로고    scopus 로고
    • Charting biologically relevant chemical space: A structural classification of natural products (SCONP)
    • Koch MA, et al. (2005) Charting biologically relevant chemical space: A structural classification of natural products (SCONP). Proc Natl Acad Sci USA 102:17272-17277.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 17272-17277
    • Koch, M.A.1
  • 11
    • 78349305618 scopus 로고    scopus 로고
    • Marine natural products as sources of novel scaffolds: Achievement and concern
    • Kong DX, Jiang YY, Zhang HY (2010) Marine natural products as sources of novel scaffolds: Achievement and concern. Drug Discov Today 15:884-886.
    • (2010) Drug Discov Today , vol.15 , pp. 884-886
    • Kong, D.X.1    Jiang, Y.Y.2    Zhang, H.Y.3
  • 14
    • 70350722394 scopus 로고    scopus 로고
    • Genomic basis for natural product biosynthetic diversity in the actinomycetes
    • Nett M, Ikeda H, Moore BS (2009) Genomic basis for natural product biosynthetic diversity in the actinomycetes. Nat Prod Rep 26:1362-1384.
    • (2009) Nat Prod Rep , vol.26 , pp. 1362-1384
    • Nett, M.1    Ikeda, H.2    Moore, B.S.3
  • 15
    • 33751100882 scopus 로고    scopus 로고
    • Developing a new resource for drug discovery: Marine actinomycete bacteria
    • Fenical W, Jensen PR (2006) Developing a new resource for drug discovery: Marine actinomycete bacteria. Nat Chem Biol 2:666-673.
    • (2006) Nat Chem Biol , vol.2 , pp. 666-673
    • Fenical, W.1    Jensen, P.R.2
  • 16
    • 0036570328 scopus 로고    scopus 로고
    • Functional versus chemical diversity: Is biodiversity important for drug discovery?
    • Tulp M, Bohlin L (2002) Functional versus chemical diversity: Is biodiversity important for drug discovery? Trends Pharmacol Sci 23:225-231.
    • (2002) Trends Pharmacol Sci , vol.23 , pp. 225-231
    • Tulp, M.1    Bohlin, L.2
  • 17
    • 14544294545 scopus 로고    scopus 로고
    • Bioactive microbial metabolites
    • Bérdy J (2005) Bioactive microbial metabolites. J Antibiot (Tokyo) 58:1-26.
    • (2005) J Antibiot (Tokyo) , vol.58 , pp. 1-26
    • Bérdy, J.1
  • 18
    • 15944368107 scopus 로고    scopus 로고
    • Rediscovery of known natural compounds: Nuisance or goldmine?
    • Tulp M, Bohlin L (2005) Rediscovery of known natural compounds: Nuisance or goldmine? Trends Pharmacol Sci 26:175-177.
    • (2005) Trends Pharmacol Sci , vol.26 , pp. 175-177
    • Tulp, M.1    Bohlin, L.2
  • 19
    • 39149137869 scopus 로고    scopus 로고
    • Plant-derived compounds in clinical trials
    • Saklani A, Kutty SK (2008) Plant-derived compounds in clinical trials. Drug Discov Today 13:161-171.
    • (2008) Drug Discov Today , vol.13 , pp. 161-171
    • Saklani, A.1    Kutty, S.K.2
  • 20
    • 77950571108 scopus 로고    scopus 로고
    • New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays
    • Baell JB, Holloway GA (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem 53:2719-2740.
    • (2010) J Med Chem , vol.53 , pp. 2719-2740
    • Baell, J.B.1    Holloway, G.A.2
  • 21
    • 77954814751 scopus 로고    scopus 로고
    • Evolving molecules using multi-objective optimization: Applying to ADME/Tox
    • Ekins S, Honeycutt JD, Metz JT (2010) Evolving molecules using multi-objective optimization: Applying to ADME/Tox. Drug Discov Today 15:451-460.
    • (2010) Drug Discov Today , vol.15 , pp. 451-460
    • Ekins, S.1    Honeycutt, J.D.2    Metz, J.T.3
  • 22
    • 69249141066 scopus 로고    scopus 로고
    • Comprehensive assessment of ADMET risks in drug discovery
    • Wang J (2009) Comprehensive assessment of ADMET risks in drug discovery. Curr Pharm Des 15:2195-2219.
    • (2009) Curr Pharm des , vol.15 , pp. 2195-2219
    • Wang, J.1
  • 24
    • 75549090848 scopus 로고    scopus 로고
    • Update of TTD: Therapeutic Target Database
    • Zhu F, et al. (2010) Update of TTD: Therapeutic Target Database. Nucleic Acids Res 38(Database issue):D787-D791.
    • (2010) Nucleic Acids Res , vol.38 , Issue.DATABASE ISSUE
    • Zhu, F.1
  • 25
    • 65449131192 scopus 로고    scopus 로고
    • Metamorphic enzyme assembly in polyketide diversification
    • Gu L, et al. (2009) Metamorphic enzyme assembly in polyketide diversification. Nature 459:731-735.
    • (2009) Nature , vol.459 , pp. 731-735
    • Gu, L.1
  • 26
    • 77950553761 scopus 로고    scopus 로고
    • Sequence-based analysis of secondary-metabolite biosynthesis in marine actinobacteria
    • Gontang EA, Gaudêncio SP, Fenical W, Jensen PR (2010) Sequence-based analysis of secondary-metabolite biosynthesis in marine actinobacteria. Appl Environ Microbiol 76:2487-2499.
    • (2010) Appl Environ Microbiol , vol.76 , pp. 2487-2499
    • Gontang, E.A.1    Gaudêncio, S.P.2    Fenical, W.3    Jensen, P.R.4
  • 27
    • 1642453829 scopus 로고    scopus 로고
    • Mining the microbial metabolome: A new frontier for natural product lead discovery
    • Perić-Concha N, Long PF (2003) Mining the microbial metabolome: A new frontier for natural product lead discovery. Drug Discov Today 8:1078-1084.
    • (2003) Drug Discov Today , vol.8 , pp. 1078-1084
    • Perić-Concha, N.1    Long, P.F.2
  • 28
    • 77649305354 scopus 로고    scopus 로고
    • Natural products version 2.0: Connecting genes to molecules
    • Walsh CT, Fischbach MA (2010) Natural products version 2.0: Connecting genes to molecules. J Am Chem Soc 132:2469-2493.
    • (2010) J Am Chem Soc , vol.132 , pp. 2469-2493
    • Walsh, C.T.1    Fischbach, M.A.2
  • 29
    • 0141829776 scopus 로고    scopus 로고
    • Phytoestrogens: A review of the present state of research
    • Ososki AL, Kennelly EJ (2003) Phytoestrogens: A review of the present state of research. Phytother Res 17:845-869.
    • (2003) Phytother Res , vol.17 , pp. 845-869
    • Ososki, A.L.1    Kennelly, E.J.2
  • 30
    • 67349098836 scopus 로고    scopus 로고
    • Distribution of the antifungal agents sordarins across filamentous fungi
    • Vicente F, et al. (2009) Distribution of the antifungal agents sordarins across filamentous fungi. Mycol Res 113:754-770.
    • (2009) Mycol Res , vol.113 , pp. 754-770
    • Vicente, F.1
  • 33
    • 67650088426 scopus 로고    scopus 로고
    • The basics of preclinical drug development for neurodegenerative disease indications
    • Steinmetz KL, Spack EG (2009) The basics of preclinical drug development for neurodegenerative disease indications. BMC Neurol 9(Suppl 1):S2 1-13.
    • (2009) BMC Neurol , vol.9 , Issue.SUPPL. 1
    • Steinmetz, K.L.1    Spack, E.G.2
  • 34
    • 71249091175 scopus 로고    scopus 로고
    • Current trends in the clinical development of peptide therapeutics
    • Saladin PM, Zhang BD, Reichert JM (2009) Current trends in the clinical development of peptide therapeutics. IDrugs 12:779-784.
    • (2009) IDrugs , vol.12 , pp. 779-784
    • Saladin, P.M.1    Zhang, B.D.2    Reichert, J.M.3
  • 35
    • 34447503942 scopus 로고    scopus 로고
    • The FDA's assessment of follow-on protein products: A historical perspective
    • Woodcock J, et al. (2007) The FDA's assessment of follow-on protein products: A historical perspective. Nat Rev Drug Discov 6:437-442.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 437-442
    • Woodcock, J.1
  • 36
    • 77957361348 scopus 로고    scopus 로고
    • Development trends for human monoclonal antibody therapeutics
    • Nelson AL, Dhimolea E, Reichert JM (2010) Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9:767-774.
    • (2010) Nat Rev Drug Discov , vol.9 , pp. 767-774
    • Nelson, A.L.1    Dhimolea, E.2    Reichert, J.M.3
  • 37
  • 38
    • 33947308882 scopus 로고    scopus 로고
    • Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans
    • Bergmann S, et al. (2007) Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. Nat Chem Biol 3:213-217.
    • (2007) Nat Chem Biol , vol.3 , pp. 213-217
    • Bergmann, S.1
  • 39
    • 27544477567 scopus 로고    scopus 로고
    • Discovery of a new peptide natural product by Streptomyces coelicolor genome mining
    • Lautru S, Deeth RJ, Bailey LM, Challis GL (2005) Discovery of a new peptide natural product by Streptomyces coelicolor genome mining. Nat Chem Biol 1:265-269.
    • (2005) Nat Chem Biol , vol.1 , pp. 265-269
    • Lautru, S.1    Deeth, R.J.2    Bailey, L.M.3    Challis, G.L.4
  • 40
    • 79851515868 scopus 로고    scopus 로고
    • Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms
    • Chiang YM, Chang SL, Oakley BR, Wang CC (2011) Recent advances in awakening silent biosynthetic gene clusters and linking orphan clusters to natural products in microorganisms. Curr Opin Chem Biol 15:137-143.
    • (2011) Curr Opin Chem Biol , vol.15 , pp. 137-143
    • Chiang, Y.M.1    Chang, S.L.2    Oakley, B.R.3    Wang, C.C.4
  • 41
    • 25144510054 scopus 로고    scopus 로고
    • Formation of novel secondary metabolites by bacterial multimodular assembly lines: Deviations from textbook biosynthetic logic
    • Wenzel SC, Müller R (2005) Formation of novel secondary metabolites by bacterial multimodular assembly lines: Deviations from textbook biosynthetic logic. Curr Opin Chem Biol 9:447-458.
    • (2005) Curr Opin Chem Biol , vol.9 , pp. 447-458
    • Wenzel, S.C.1    Müller, R.2
  • 42
    • 34250701119 scopus 로고    scopus 로고
    • Mining and engineering natural-product biosynthetic pathways
    • Wilkinson B, Micklefield J (2007) Mining and engineering natural-product biosynthetic pathways. Nat Chem Biol 3:379-386.
    • (2007) Nat Chem Biol , vol.3 , pp. 379-386
    • Wilkinson, B.1    Micklefield, J.2
  • 43
    • 12244273677 scopus 로고    scopus 로고
    • Occurrence and non-detectability of maytansinoids in individual plants of the genera Maytenus and Putterlickia
    • Pullen CB, et al. (2003) Occurrence and non-detectability of maytansinoids in individual plants of the genera Maytenus and Putterlickia. Phytochemistry 62:377-387.
    • (2003) Phytochemistry , vol.62 , pp. 377-387
    • Pullen, C.B.1
  • 44
    • 70149109184 scopus 로고    scopus 로고
    • Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans
    • Schroeckh V, et al. (2009) Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans. Proc Natl Acad Sci USA 106:14558-14563.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 14558-14563
    • Schroeckh, V.1
  • 45
    • 54849405130 scopus 로고    scopus 로고
    • Renaissance in antibacterial discovery from actinomycetes
    • Baltz RH (2008) Renaissance in antibacterial discovery from actinomycetes. Curr Opin Pharmacol 8:557-563.
    • (2008) Curr Opin Pharmacol , vol.8 , pp. 557-563
    • Baltz, R.H.1
  • 46
    • 33750435937 scopus 로고    scopus 로고
    • Marine natural products: Drugs from the deep
    • Marris E (2006) Marine natural products: Drugs from the deep. Nature 443:904-905.
    • (2006) Nature , vol.443 , pp. 904-905
    • Marris, E.1
  • 47
    • 77953685524 scopus 로고    scopus 로고
    • The odyssey of marine pharmaceuticals: A current pipeline perspective
    • Mayer AM, et al. (2010) The odyssey of marine pharmaceuticals: A current pipeline perspective. Trends Pharmacol Sci 31:255-265.
    • (2010) Trends Pharmacol Sci , vol.31 , pp. 255-265
    • Mayer, A.M.1
  • 48
    • 34548227773 scopus 로고    scopus 로고
    • From exotic spice to modern drug?
    • Singh S (2007) From exotic spice to modern drug? Cell 130:765-768.
    • (2007) Cell , vol.130 , pp. 765-768
    • Singh, S.1
  • 49
    • 34848923305 scopus 로고    scopus 로고
    • Marine natural products of fungal origin
    • Saleem M, et al. (2007) Marine natural products of fungal origin. Nat Prod Rep 24: 1142-1152.
    • (2007) Nat Prod Rep , vol.24 , pp. 1142-1152
    • Saleem, M.1
  • 50
    • 77951569850 scopus 로고    scopus 로고
    • Antiviral and anti-inflammatory metabolites from the soft coral Sinularia capillosa
    • Cheng SY, et al. (2010) Antiviral and anti-inflammatory metabolites from the soft coral Sinularia capillosa. J Nat Prod 73:771-775.
    • (2010) J Nat Prod , vol.73 , pp. 771-775
    • Cheng, S.Y.1
  • 51
    • 34147178918 scopus 로고    scopus 로고
    • Neurotoxins from invertebrates as anticonvulsants: From basic research to therapeutic application
    • Mortari MR, Cunha AO, Ferreira LB, dos Santos WF (2007) Neurotoxins from invertebrates as anticonvulsants: From basic research to therapeutic application. Pharmacol Ther 114:171-183.
    • (2007) Pharmacol Ther , vol.114 , pp. 171-183
    • Mortari, M.R.1    Cunha, A.O.2    Ferreira, L.B.3    Dos Santos, W.F.4
  • 52
    • 33646754515 scopus 로고    scopus 로고
    • Therapeutic targets: Progress of their exploration and investigation of their characteristics
    • Zheng CJ, et al. (2006) Therapeutic targets: Progress of their exploration and investigation of their characteristics. Pharmacol Rev 58:259-279.
    • (2006) Pharmacol Rev , vol.58 , pp. 259-279
    • Zheng, C.J.1
  • 54
    • 23044490704 scopus 로고    scopus 로고
    • Plants as a source of anti-cancer agents
    • Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100:72-79.
    • (2005) J Ethnopharmacol , vol.100 , pp. 72-79
    • Cragg, G.M.1    Newman, D.J.2
  • 55
    • 0034237675 scopus 로고    scopus 로고
    • Strategies for discovering drugs from previously unexplored natural products
    • Harvey A (2000) Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 5:294-300.
    • (2000) Drug Discov Today , vol.5 , pp. 294-300
    • Harvey, A.1
  • 56
    • 64549150542 scopus 로고    scopus 로고
    • Triggering cryptic natural product biosynthesis in microorganisms
    • Scherlach K, Hertweck C (2009) Triggering cryptic natural product biosynthesis in microorganisms. Org Biomol Chem 7:1753-1760.
    • (2009) Org Biomol Chem , vol.7 , pp. 1753-1760
    • Scherlach, K.1    Hertweck, C.2
  • 58
    • 58149200954 scopus 로고    scopus 로고
    • Database resources of the National Center for Biotechnology Information
    • Sayers EW, et al. (2009) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 37(Database issue):D5-D15.
    • (2009) Nucleic Acids Res , vol.37 , Issue.DATABASE ISSUE
    • Sayers, E.W.1
  • 59
    • 33644700003 scopus 로고    scopus 로고
    • Toward automatic reconstruction of a highly resolved tree of life
    • Ciccarelli FD, et al. (2006) Toward automatic reconstruction of a highly resolved tree of life. Science 311:1283-1287.
    • (2006) Science , vol.311 , pp. 1283-1287
    • Ciccarelli, F.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.